Prof. Dr. Vishwanath Venkentaraman is a Professor at the
College of Osteopathic Medicine of Pacific, Western University of Health
Sciences, CA. Upon completion of his doctorate in microbiology and immunology
at the Tuberculosis Research Center in Chennai, India, he was awarded a UNESCO
fellowship to conduct post-doctoral research on tuberculosis at the University
of Ferrara, Italy. He continued his post-doctoral research at the University of
Michigan Medical School and the UMDNJ-New Jersey Medical School. He has been
awarded the Provost’s Distinguished Scholar Award from Western University of
Health Sciences in 2019, Best Professor Award-2019 (as voted by the Master’s
students (MSMS program) from the class of 2019 Graduate College of Biomedical
Sciences, Western University of Health Sciences). He and his team study the
pathophysiology of tuberculosis in the context of HIV co-infection and type II
diabetes. They recently conducted a clinical trial in HIV-positive individuals
to test the efficacy of liposomal glutathione (L-GSH) in restoring the levels
of GSH and improving the functions of immune cells.
Prof. Dr. Vishwanath Venkentaraman is a Professor at the
College of Osteopathic Medicine of Pacific, Western University of Health
Sciences, CA. Upon completion of his doctorate in microbiology and immunology
at the Tuberculosis Research Center in Chennai, India, he was awarded a UNESCO
fellowship to conduct post-doctoral research on tuberculosis at the University
of Ferrara, Italy. He continued his post-doctoral research at the University of
Michigan Medical School and the UMDNJ-New Jersey Medical School. He has been
awarded the Provost’s Distinguished Scholar Award from Western University of
Health Sciences in 2019, Best Professor Award-2019 (as voted by the Master’s
students (MSMS program) from the class of 2019 Graduate College of Biomedical
Sciences, Western University of Health Sciences). He and his team study the
pathophysiology of tuberculosis in the context of HIV co-infection and type II
diabetes. They recently conducted a clinical trial in HIV-positive individuals
to test the efficacy of liposomal glutathione (L-GSH) in restoring the levels
of GSH and improving the functions of immune cells.